Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001983699 | SCV002278298 | uncertain significance | not provided | 2021-12-07 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. This variant has not been reported in the literature in individuals affected with RBBP8-related conditions. This variant is present in population databases (rs757282598, gnomAD 0.01%). This sequence change falls in intron 12 of the RBBP8 gene. It does not directly change the encoded amino acid sequence of the RBBP8 protein. |
Fulgent Genetics, |
RCV002507761 | SCV002815635 | uncertain significance | Jawad syndrome; Seckel syndrome 2 | 2022-01-25 | criteria provided, single submitter | clinical testing |